BRL 35135
BRL 35135 is a potent and selective β3-adrenergic receptor agonist. BRL 35135 can dose dependently increase energy expenditure, reduce weight, and only reduce fat without reducing muscle protein. BRL 35135 can significantly improve glucose tolerance and insulin sensitivity. BRL 35135 can be used to study metabolic conditions such as obesity and diabetes[1].
Product Specifications
CAS Number
[86615-96-5]
UNSPSC
12352005
Target
Adrenergic Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Smiles
COC(COC(C=C1)=CC=C1C[C@H](C)NC[C@H](C2=CC(Cl)=CC=C2)O)=O
Molecular Formula
C20H24ClNO4
Molecular Weight
377.86
References & Citations
[1]Cawthorne MA, et al. BRL 35135, a potent and selective atypical beta-adrenoceptor agonist. Am J Clin Nutr. 1992 Jan;55 (1 Suppl) :252S-257S.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
β adrenergic receptor
Explore Other Products
Browse additional items from our catalog
TAC2N, NT (TC2N, C14orf47, MTAC2D1, Tandem C2 domains nuclear protein, Membrane targeting tandem C2 domain-containing protein 1, Tandem C2 protein in nucleus)
TAC2N, NT (TC2N, C14orf47, MTAC2D1, Tandem C2 domains nuclear protein, Membrane targeting tandem C2 domain-containing protein 1, Tandem C2 protein in nucleus)
